NYSE:BHC (Bausch Health Companies Inc.)
About BHC
A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Bausch Health Companies Inc. (NYSE: BHC) Latest News

Investing
These Were the Worst-Performing Stocks on the TSX Last Week

Investing
Is it Time to Reconsider Bausch Health (TSX:BHC)?

Investing
This Healthcare Stock Defied Gravity in its Heyday: Today, it Is Undervalued

Dividend Stocks
Value Investors: These 3 Stocks Are Ridiculously Cheap

Investing
Why TransCanada’s Name Change Could Be a Big Move for the Stock

Investing
Why This Fallen Investor Darling Soared Almost 10% Yesterday

Investing
Why I’m Finally Revisiting This Former Growth Investment

Tech Stocks
2 Forgotten Investments That You May Want to Reconsider

Investing
1 Forgotten Canadian Stock That Could Make You Filthy Rich

Investing
Up 30% in the Last Year, Bausch Health Companies (TSX:BHC) Shows Continued Progress

Investing
Profit from Panic: 3 Top Contrarian Stocks to Buy Now
